InnoCore and Nanomi strengthen collaboration in microsphere technology for peptide and protein delivery
InnoCore Technologies BV and Nanomi BV announced a strategic collaboration for the development of advanced monodisperse biodegradable microsphere-based controlled release formulations. Under this collaboration the companies will jointly offer their combined proprietary SynBiosys™ and Monosphere™ technologies to the market as a powerful platform technology for the sustained delivery of biotherapeutics.
This decision follows the successful completion of a joint R&D program in which the companies combined InnoCore’s versatile and adjustable biodegradable polymeric SynBiosys drug delivery platform with Nanomi’s robust and scalable microsieve™ emulsification based Monosphere process technology. The combination offers an attractive route towards the development of minimally invasive and less painful injectable controlled release depot formulations for the systemic or site-specific delivery of even the most challenging biological molecules.
Other news from the department business & finance
